These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 121957)

  • 21. Managing hematologic toxicities.
    Capo G; Waltzman R
    J Support Oncol; 2004; 2(1):65-79. PubMed ID: 15330374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen-induced myelotoxicity in dogs: A review.
    Sontas HB; Dokuzeylu B; Turna O; Ekici H
    Can Vet J; 2009 Oct; 50(10):1054-8. PubMed ID: 20046604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy.
    Blumenthal RD; Lew W; Juweid M; Alisauskas R; Ying Z; Goldenberg DM
    Cancer; 2000 Jan; 88(2):333-43. PubMed ID: 10640965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.
    Ganti AK; Landmark JD; Kessinger A; Smith LM; Tarantolo SR
    In Vivo; 2006; 20(4):559-63. PubMed ID: 16900790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of lithium on leukocytes: a two-year follow-up.
    Pi EH; Sramek JJ; Simpson GM
    J Clin Psychiatry; 1983 Apr; 44(4):139-40. PubMed ID: 6833200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
    Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
    Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
    [No Abstract]   [Full Text] [Related]  

  • 29. [Principal clinical indications for direct transfusion therapy].
    Silvestri G; Radicioni P
    Minerva Med; 1977 Sep; 68(42):2983-92. PubMed ID: 909645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
    Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induction therapy of acute leukemia in children. Current results and problems related to therapeutic aplasia. Apropos of 146 cases].
    Leverger G; Bancillon A; Douard MC; Benbunan M; Schaison G
    Arch Fr Pediatr; 1986 Mar; 43(3):161-5. PubMed ID: 3463251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lithium and acute myeloid leukemia].
    Witz F; Rigon JL; Lederlin P; Aymard JP; Rumilly F; Eisenmann JC; Herbeuval R
    Sem Hop; 1983 Feb; 59(8):559-60. PubMed ID: 6302903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
    DuBois SG; Messina J; Maris JM; Huberty J; Glidden DV; Veatch J; Charron M; Hawkins R; Matthay KK
    J Clin Oncol; 2004 Jun; 22(12):2452-60. PubMed ID: 15197208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Specific hemotherapy].
    Stich W
    Internist (Berl); 1969 Feb; 10(2):52-8. PubMed ID: 4188581
    [No Abstract]   [Full Text] [Related]  

  • 37. [Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
    Invernizzi R
    Minerva Med; 1980 Nov; 71(44):3247-50. PubMed ID: 6935535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombocytopenia after autologous bone marrow transplantation in in acute lymphatic leukemia].
    Siegert E; Lauterbach I; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):265-70. PubMed ID: 1697828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intensive cytostatic therapy of acute lymphatic leukemia in children during the period 1968-1975].
    Brincker H; Laursen AM; Lochte J
    Ugeskr Laeger; 1975 Dec; 137(51):3021-4. PubMed ID: 1060211
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of lithium carbonate in treatment of central granulocytopenias.
    Popa G; Hanganu E; Iordăcheanu L; Iosifescu V; Ciochină AD; Hurjui V; Gălăţeanu L; Pintilie S
    Rev Med Chir Soc Med Nat Iasi; 1982; 86(4):589-91. PubMed ID: 6820544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.